Author: admin

  • Tristram Hunt – 2016 Parliamentary Question to the Department of Health

    Tristram Hunt – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Tristram Hunt on 2016-02-24.

    To ask the Secretary of State for Health, what progress his Department has made on developing a national measure of child development at age two to two-and-a-half as part of the public health framework; and when he expects that measure to be introduced.

    Jane Ellison

    The Department is leading work to develop an indicator of child development at age 2-2½ to be included in the Public Health Outcomes Framework (PHOF) from 2017. The population measure will give a national picture of child development at age 2 and will also help local areas to assess the impact of services for 0-2 year olds and inform local commissioning.

    Since April 2015, the Department has asked all health visiting teams in England to use the evidence based Ages and Stages Questionnaires (ASQ-3) as part of children’s health and development reviews at age 2-2½ to generate data for the indicator. The Department has worked with Health Education England to develop e-learning materials to support health professionals using ASQ-3 as part of the two year review.

    From October 2015, health visiting providers were asked to report ASQ-3 scores to the Children and Young People’s Health Services dataset, which is being developed by the Health and Social Care Information Centre. The dataset is expected to publish its first report in April 2016.

    Public Health England will draw on ASQ-3 data from the children’s dataset to report the PHOF outcome measure of child development at age 2-2½, reporting on a yearly basis the percentage of children with a positive outcome across all five domains of development in ASQ-3 at age 2-2½. The first reporting of the outcome measure is planned for inclusion in the PHOF in spring 2017.

  • Sheryll Murray – 2016 Parliamentary Question to the Department of Health

    Sheryll Murray – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Sheryll Murray on 2016-02-24.

    To ask the Secretary of State for Health, what estimates he has made of the additional resources needed and the cost of providing additional dialysis capacity for those patients who will no longer be suitable for a kidney transplant and for those patients whose transplant graft fails due as a result of restrictions in the range of immunosuppressant agents that will be introduced if the recommendations of the NICE review of TA 85 [ID456] are upheld at appeal.

    George Freeman

    We have made no such assessment.

    The National Institute for Health and Care Excellence (NICE) has not yet published its final updated guidance on the use of immunosuppressive therapy for kidney transplant in adults (review of TA85) or on the use of immunosuppressive therapy for kidney transplant in children and young people (review of TA99). NICE is developing resource impact reports to support implementation of its guidance which will be published alongside its final technology appraisal guidance.

  • David Winnick – 2016 Parliamentary Question to the Department of Health

    David Winnick – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by David Winnick on 2016-02-24.

    To ask the Secretary of State for Health, what plans he has to urgently consult with medical authorities on ensuring a meningitis B vaccine is provided to all young children; and if he will make a statement.

    Jane Ellison

    National immunisation programmes are introduced on the advice of the Joint Committee on Vaccination and Immunisation (JCVI), the independent expert body that advises the Government on all immunisation matters. JCVI’s recommendations are based on a comprehensive and careful review of a wide range of evidence including information from medical experts.

    JCVI reviewed the available evidence on meningitis B vaccine and recommended a national Meningococcal B (MenB) immunisation programme for infants. The MenB vaccine is first offered to babies at 2 months of age, with further doses offered when they reach 4 and 12 months of age.

    MenB was introduced into the NHS programme in September 2015. JCVI keeps the eligibility criteria of all vaccination programmes under review and considers new evidence as it becomes available. If JCVI provides further advice about the programme, we will consider this.

  • Sheryll Murray – 2016 Parliamentary Question to the Department of Health

    Sheryll Murray – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Sheryll Murray on 2016-02-24.

    To ask the Secretary of State for Health, what assessment his Department has made of the potential effect on (a) resourcing of kidney and dialysis care in Plymouth Hospitals and Royal Cornwall Hospitals NHS Trusts and (b) care for kidney patients from South East Cornwall of the recent NICE ruling on provision of immune-suppressant drugs.

    George Freeman

    We have made no such assessment.

    The National Institute for Health and Care Excellence (NICE) has not yet published its final updated guidance on the use of immunosuppressive therapy for kidney transplant in adults (review of TA85) or on the use of immunosuppressive therapy for kidney transplant in children and young people (review of TA99). NICE is developing resource impact reports to support implementation of its guidance which will be published alongside its final technology appraisal guidance.

  • Steve McCabe – 2016 Parliamentary Question to the Department of Health

    Steve McCabe – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Steve McCabe on 2016-02-24.

    To ask the Secretary of State for Health, pursuant to the Answer of 22 February 2016 to Question 26546, when he expects to publish the consultation document on introducing fixed recoverable costs in clinical negligence claims.

    Ben Gummer

    We are planning to go out to consultation shortly.

  • David Winnick – 2016 Parliamentary Question to the Department of Health

    David Winnick – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by David Winnick on 2016-02-24.

    To ask the Secretary of State for Health, when his Department last consulted medical authorities on the potential merits of making the meningitis B vaccine available on the NHS for all children; and if he will make a statement.

    Jane Ellison

    National immunisation programmes are introduced on the advice of the Joint Committee on Vaccination and Immunisation (JCVI), the independent expert body that advises the Government on all immunisation matters. JCVI’s recommendations are based on a comprehensive and careful review of a wide range of evidence including information from medical experts.

    JCVI reviewed the available evidence on meningitis B vaccine and recommended a national Meningococcal B (MenB) immunisation programme for infants. The MenB vaccine is first offered to babies at 2 months of age, with further doses offered when they reach 4 and 12 months of age.

    MenB was introduced into the NHS programme in September 2015. JCVI keeps the eligibility criteria of all vaccination programmes under review and considers new evidence as it becomes available. If JCVI provides further advice about the programme, we will consider this.

  • David Winnick – 2016 Parliamentary Question to the Department of Health

    David Winnick – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by David Winnick on 2016-02-24.

    To ask the Secretary of State for Health, whether he plans to meet Mr and Mrs Timmins to discuss the death in 2013 of their son from meningitis B and the future provision of a vaccine for that disease on the NHS; and if he will make a statement.

    Jane Ellison

    Meningococcal B (MenB) disease is a devastating disease which can have tragic consequences. We understand that in March 2014 Mr and Mrs Timmins met consultants at Walsall Healthcare NHS Trust to discuss their son’s care following his tragic death in December 2013.

    In September 2015, we became the first country in the world to offer a national and publicly funded MenB immunisation programme using the Bexsero vaccine to protect infants. The programme follows the advice of the Joint Committee on Vaccination and Immunisation, the independent, expert body which advises Government on all immunisation matters. Infants are vaccinated at two months of age, with further doses offered when they reach four and 12 months of age, thereby protecting groups with the highest risk.

  • Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    Andrew Gwynne – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Andrew Gwynne on 2016-02-24.

    To ask the Secretary of State for Health, what proportion of the £570 million referred to in paragraph 0.5 of his Department’s paper, Infected blood: reform of financial and other support, published in January 2016, will be spent in each year of the programme; what the average spend per recipient will be in each such year; and in what categories of spending that funding will fall in each such year.

    Jane Ellison

    The Department estimates that it would pay out £570 million over the next 45 years, based on the existing unreformed scheme. The Department currently anticipates that it will disburse the same sum under a reformed scheme plus the additional £125 million over the current spending review period of five years. We are currently consulting on the reformed scheme and are unable to estimate the future average annual spend beyond the current spending review or the categories of spend for the period. For the current spending review period the planned expenditure is £47.5 million for each of the next five years.

  • Sadiq Khan – 2016 Parliamentary Question to the Home Office

    Sadiq Khan – 2016 Parliamentary Question to the Home Office

    The below Parliamentary question was asked by Sadiq Khan on 2016-02-24.

    To ask the Secretary of State for the Home Department, on how many occasions custody nurses were not available in police stations when required in each year since 2010.

    Mike Penning

    The provision and commissioning of police custody nurses is the responsibility of individual Police and Crime Commissioners, and police custody nurse staffing and availability levels are an operational policing matter in conjunction with the custody healthcare service provider. Information on these issues is not held centrally by the Home Office.

  • Norman Lamb – 2016 Parliamentary Question to the Department of Health

    Norman Lamb – 2016 Parliamentary Question to the Department of Health

    The below Parliamentary question was asked by Norman Lamb on 2016-02-24.

    To ask the Secretary of State for Health, with reference to paragraph 2 of Delivering the Forward View: NHS Planning Guidance, published in December 2015, how much of the £8.4 billion real terms increase in NHS funding by 2020-21 is allocated to mental health; whether that figure includes funding for children and young people’s mental health announced before the 2015 General Election; and under which of his Department’s budget headings that funding has been allocated.

    Alistair Burt

    Regarding the £8.4 billion real terms increase in funding, NHS England (NHSE) does not stipulate a specific spend level for commissioning bodies, this is to be determined by national policy directives like parity of esteem and specific local needs based assessment. At a commissioning stream level, NHSE has set a principal commitment to achieving mental health parity of esteem. Through its assurance process NHSE will hold individual commissioners to account for increasing spend on mental health in line with their increase in allocations, taking account of the additional mental health funding that has been received.

    The difference between the 2015/16 funding for children’s and young people’s mental health in NHSE baseline and subsequent increase in funding over the five-year period from 2016-17 to 2020-21 is included in the £8.4 billion growth in the Mandate.

    The Department allocates funding to NHS England as set out in the government’s mandate to NHSE and accompanying financial directions. The mandate to NHSE for 2016-17 and accompanying directions are both available at:

    https://www.gov.uk/government/publications/nhs-mandate-2016-to-2017

    “